Dyne Therapeutics (NASDAQ:DYN – Get Rating) released its quarterly earnings data on Thursday. The company reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.99) by ($0.01), MarketWatch Earnings reports. NASDAQ:DYN traded down $0.26 during trading hours on Friday, hitting $8.74. 1,428 shares of the stock were exchanged, compared to its […]
A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease.
Dyne Therapeutics Highlights Preclinical Data and Clinical Development Plans for DMD and DM1 Programs at Inaugural R&D Day forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Chutes & Ladders—Genzyme vet Sherblom joins ReForm amid subcutaneous delivery shift fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.